• 2098 Citations
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Clinical and translational research related to pediatric stem cell transplantation especially as it relates to safety and reduced intensity without compromising efficacy.

Areas of Clinical Interest

Transplantation biology, immunologic mechanisms of graft rejection, graft versus host disease, stem cell transplantation, unrelated donor transplantation for severe sickle cell disease,

Fingerprint Dive into the research topics where Shalini Shenoy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Ngwube, A., Shah, N., Godder, K., Jacobsohn, D., Hulbert, M. & Shenoy, S., Aug 25 2020, In : Blood Advances. 4, 16, p. 3894-3899 6 p.

Research output: Contribution to journalArticle

  • A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study

    Davies, S. M., Iannone, R., Alonzo, T. A., Wang, Y. C., Gerbing, R., Soni, S., Kolb, E. A., Meshinchi, S., Orchard, P. J., Burns, L. J., Shenoy, S. & Leung, W., Apr 2020, In : Biology of Blood and Marrow Transplantation. 26, 4, p. 712-717 6 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A Perspective

    Zimmerman, C. & Shenoy, S., Aug 11 2020, In : Frontiers in immunology. 11, 1791.

    Research output: Contribution to journalArticle

    Open Access
  • Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT (Journal of Clinical Immunology, (2019), 39, 7, (653-667), 10.1007/s10875-019-00659-8)

    submitted on behalf of the Primary Immune Deficiency Treatment Consortium, 2020, (Accepted/In press) In : Journal of Clinical Immunology.

    Research output: Contribution to journalComment/debate

    Open Access